Inhibikase Therapeutics Inc (NAS:IKT)
$ 2.73 0.37 (15.68%) Market Cap: 183.44 Mil Enterprise Value: 155.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100